Search research articles
Contact Us
Filters
Showing results (1-10 of 73) with videos related to
Page
of 8
Sort By:
PET Clinics
|
May 1, 2026
Theranostics: When Targeted Imaging Guides Targeted Therapy
Harshad R Kulkarni
PET Clinics
|
April 10, 2026
From Feasibility to Durability: The Next Phase of Theranostics
Harshad R Kulkarni, Abass Alavi
PET Clinics
|
October 13, 2022
Precision Imaging of Prostate Cancer
Harshad R Kulkarni, Abass Alavi
Theranostics
|
July 7, 2012
THERANOSTICS: From Molecular Imaging Using Ga-68 Labeled Tracers and PET/CT to Personalized Radionuclide Therapy - The Bad Berka Experience
Richard P Baum, Harshad R Kulkarni
PET Clinics
|
July 18, 2014
Theranostics with Ga-68 somatostatin receptor PET/CT: monitoring response to peptide receptor radionuclide therapy
Harshad R Kulkarni, Richard P Baum
PET Clinics
|
July 18, 2014
Patient selection for personalized peptide receptor radionuclide therapy using Ga-68 somatostatin receptor PET/CT
Harshad R Kulkarni, Richard P Baum
Clinical Nuclear Medicine
|
January 25, 2020
Peptide Receptor Radionuclide Therapy Using 225Ac-DOTATOC Achieves Partial Remission in a Patient With Progressive Neuroendocrine Liver Metastases After Repeated β-Emitter Peptide Receptor Radionuclide Therapy
Jingjing Zhang, Harshad R Kulkarni, Richard P Baum
Clinical Nuclear Medicine
|
July 9, 2021
225Ac-DOTATOC-Targeted Somatostatin Receptor α-Therapy in a Patient With Metastatic Neuroendocrine Tumor of the Thymus, Refractory to β-Radiation
Jingjing Zhang, Harshad R Kulkarni, Richard P Baum
PET Clinics
|
March 8, 2017
Imaging of Prostate Cancer Using <sup>64</sup>Cu-Labeled Prostate-Specific Membrane Antigen Ligand
Aviral Singh, Harshad R Kulkarni, Richard P Baum
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
August 25, 2012
Rare metastases detected by (68)Ga-somatostatin receptor PET/CT in patients with neuroendocrine tumors
Cecilia Carreras, Harshad R Kulkarni, Richard P Baum
Page
of 8
Search research articles
Search
Showing results (1-10 of 73) with videos related to
Sort By:
Page
of 8
PET Clinics
|
May 1, 2026
Theranostics: When Targeted Imaging Guides Targeted Therapy
Harshad R Kulkarni
PET Clinics
|
April 10, 2026
From Feasibility to Durability: The Next Phase of Theranostics
Harshad R Kulkarni, Abass Alavi
PET Clinics
|
October 13, 2022
Precision Imaging of Prostate Cancer
Harshad R Kulkarni, Abass Alavi
Theranostics
|
July 7, 2012
THERANOSTICS: From Molecular Imaging Using Ga-68 Labeled Tracers and PET/CT to Personalized Radionuclide Therapy - The Bad Berka Experience
Richard P Baum, Harshad R Kulkarni
PET Clinics
|
July 18, 2014
Theranostics with Ga-68 somatostatin receptor PET/CT: monitoring response to peptide receptor radionuclide therapy
Harshad R Kulkarni, Richard P Baum
PET Clinics
|
July 18, 2014
Patient selection for personalized peptide receptor radionuclide therapy using Ga-68 somatostatin receptor PET/CT
Harshad R Kulkarni, Richard P Baum
Clinical Nuclear Medicine
|
January 25, 2020
Peptide Receptor Radionuclide Therapy Using 225Ac-DOTATOC Achieves Partial Remission in a Patient With Progressive Neuroendocrine Liver Metastases After Repeated β-Emitter Peptide Receptor Radionuclide Therapy
Jingjing Zhang, Harshad R Kulkarni, Richard P Baum
Clinical Nuclear Medicine
|
July 9, 2021
225Ac-DOTATOC-Targeted Somatostatin Receptor α-Therapy in a Patient With Metastatic Neuroendocrine Tumor of the Thymus, Refractory to β-Radiation
Jingjing Zhang, Harshad R Kulkarni, Richard P Baum
PET Clinics
|
March 8, 2017
Imaging of Prostate Cancer Using <sup>64</sup>Cu-Labeled Prostate-Specific Membrane Antigen Ligand
Aviral Singh, Harshad R Kulkarni, Richard P Baum
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
August 25, 2012
Rare metastases detected by (68)Ga-somatostatin receptor PET/CT in patients with neuroendocrine tumors
Cecilia Carreras, Harshad R Kulkarni, Richard P Baum
Page
of 8